Search Results

There are 659378 results for: content related to: A New Generation of Drugs in Cancer Treatment: Molecularly Targeted Therapies

  1. Identifying New Targets for Personalised Cancer Therapy

    Standard Article


    W Link, PA Madureira and R Hill

    Published Online : 15 MAY 2013, DOI: 10.1002/9780470015902.a0024865

  2. Pharmacogenomics of Dasatinib (Sprycel™)

    Kinase Inhibitor Drugs

    Fei Huang, Edwin A. Clark, Pages: 365–402, 2009

    Published Online : 28 SEP 2009, DOI: 10.1002/9780470524961.ch15

  3. Molecular Pathogenesis of BCR-ABL in Chronic Myeloid Leukemia

    Advances in Malignant Hematology

    Eric Padron, Lori A. Hazlehurst, Javier Pinilla-Ibarz, Pages: 62–70, 2011

    Published Online : 24 MAR 2011, DOI: 10.1002/9781444394016.ch4

  4. You have full text access to this OnlineOpen article
    Intracellular signals of lung cancer cells as possible therapeutic targets

    Cancer Science

    Volume 106, Issue 5, May 2015, Pages: 489–496, Kiyomichi Tanaka, Keiki Kumano and Hiroo Ueno

    Article first published online : 20 MAR 2015, DOI: 10.1111/cas.12643

  5. Optimal Biological Dose for Molecularly Targeted Therapies

    Methods and Applications of Statistics in Clinical Trials: Planning, Analysis, and Inferential Methods, Volume 2

    Chul Ahn, Seung-Ho Kang, Yang Xie, Pages: 496–505, 2014

    Published Online : 13 JUN 2014, DOI: 10.1002/9781118596333.ch29

  6. You have free access to this content
    New molecularly targeted therapies against advanced hepatocellular carcinoma: From molecular pathogenesis to clinical trials and future directions

    Hepatology Research

    Volume 45, Issue 10, October 2015, Pages: E1–E11, Makoto Chuma, Katsumi Terashita and Naoya Sakamoto

    Article first published online : 9 JAN 2015, DOI: 10.1111/hepr.12459

  7. Heart Failure Caused by Molecularly Targeted Therapies for Cancer

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 31, Issue 1, January 2011, Pages: 62–75, Dr. Anthony Jarkowski III, Ashley E. Glode, Dr. Edward J. Spangenthal and Dr. Michael K. K. Wong

    Article first published online : 6 JAN 2012, DOI: 10.1592/phco.31.1.62

  8. Setting the Paradigm of Targeted Drugs for the Treatment of Cancer: Imatinib and Nilotinib, Therapies for Chronic Myelogenous Leukemia

    Case Studies in Modern Drug Discovery and Development

    Paul W. Manley, Jürg Zimmermann, Pages: 88–102, 2012

    Published Online : 21 MAY 2012, DOI: 10.1002/9781118219683.ch5

  9. Pursuit of Personalized Anticancer Therapy: Leveraging Collaboration Between Academia and the Biotech/Pharmaceutical Industry

    Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine

    Volume 77, Issue 4, July/August 2010, Pages: 358–365, Elizabeth Buck, Mark Mulvihill and Kenneth K. Iwata

    Article first published online : 15 JUL 2010, DOI: 10.1002/msj.20195

  10. You have free access to this content
    Development of sorafenib and other molecularly targeted agents in hepatocellular carcinoma


    Volume 112, Issue 2, 15 January 2008, Pages: 250–259, Andrew X. Zhu

    Article first published online : 26 NOV 2007, DOI: 10.1002/cncr.23175

  11. You have free access to this content
    BRAF, a target in melanoma


    Volume 116, Issue 21, 1 November 2010, Pages: 4902–4913, Keith T. Flaherty and Grant McArthur

    Article first published online : 13 JUL 2010, DOI: 10.1002/cncr.25261

  12. Tyrosine Kinase Inhibitors

    Targeting Protein Kinases for Cancer Therapy

    David J. Matthews, Mary E. Gerritsen, Pages: 435–525, 2010

    Published Online : 11 MAR 2010, DOI: 10.1002/9780470555293.ch8

  13. Personalised cancer medicine

    International Journal of Cancer

    Volume 137, Issue 2, 15 July 2015, Pages: 262–266, Sarah E. Jackson and John D. Chester

    Article first published online : 12 MAY 2014, DOI: 10.1002/ijc.28940

  14. Chronic Myeloid Leukemia

    Pediatric Hematology, Third Edition

    Irene A.G. Roberts, Inderjeet S. Dokal, Pages: 384–404, 2007

    Published Online : 4 OCT 2007, DOI: 10.1002/9780470987001.ch17

  15. You have free access to this content
    Potential role of molecularly targeted therapy in the management of advanced nonsmall cell lung carcinoma in the elderly


    Volume 101, Issue 8, 15 October 2004, Pages: 1733–1744, Cesare Gridelli, Erminia Massarelli, Paolo Maione, Antonio Rossi, Roy S. Herbst, Amir Onn and Fortunato Ciardiello

    Article first published online : 8 SEP 2004, DOI: 10.1002/cncr.20572

  16. New insights into small-molecule inhibitors of Bcr-Abl

    Medicinal Research Reviews

    Volume 31, Issue 1, January 2011, Pages: 1–41, S. Schenone, O. Bruno, M. Radi and M. Botta

    Article first published online : 27 AUG 2009, DOI: 10.1002/med.20175

  17. Pilomyxoid astrocytoma treated successfully with vemurafenib

    Pediatric Blood & Cancer

    Volume 61, Issue 11, November 2014, Pages: 2099–2100, Mary Skrypek, Nicholas Foreman, Daniel Guillaume and Christopher Moertel

    Article first published online : 12 MAY 2014, DOI: 10.1002/pbc.25084

  18. Targeted therapy in haematological malignancies

    The Journal of Pathology

    Volume 220, Issue 4, March 2010, Pages: 404–418, Ashley Hamilton, Paolo Gallipoli, Emma Nicholson and Tessa L Holyoake

    Article first published online : 10 DEC 2009, DOI: 10.1002/path.2669

  19. Oral Chemotherapeutic Agents

    Standard Article

    Encyclopedia of Drug Metabolism and Interactions

    Shin Ogita, Patricia LoRusso and Jing Li

    Published Online : 15 MAY 2012, DOI: 10.1002/9780470921920.edm132

  20. Novel agents to override imatinib resistance mechanisms

    Drug Development Research

    Volume 69, Issue 7, November 2008, Pages: 398–406, Asumi Yokota and Shinya Kimura

    Article first published online : 23 DEC 2008, DOI: 10.1002/ddr.20271